Articles Mentioning Healthcare Stocks

Results 1 - 10 of 449 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare

Investing | July 28, 2016

Why Alere Inc. Climbed 21% Today

The company is reassuring investors that a new investigation into its billing practices isn't a big deal.

Investing | July 25, 2016

These 5 Healthcare Stocks Are Ridiculously Cheap

Looking for bargains in the sector best positioned to ride aging demographic trends? These five are screaming buys.

Investing | July 15, 2016

The Reason Behind Alere Inc.'s Double-Digit Percentage Gain on Friday

The smoke is beginning to clear, and one Wall Street investment bank likes what it sees.

Investing | June 12, 2016

Is Acadia Pharmaceuticals' Stock Still a Buy?

Acadia's newly approved Parkison's disease drug could trigger a buyout. Here's why.

Investing | June 11, 2016

George Soros' Worst-Performing Stocks of 2016 So Far

A collection of underperforming stocks held by Soros Fund Management that could be set to bounce strongly.

Investing | June 04, 2016

3 Biotechs Expecting Market-Moving Trial Results Soon

Achillion Pharmaceuticals, Ophthotech Corp., and Kite Pharmaceuticals shares could move wildly because of upcoming trial data.

Investing | May 24, 2016

Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1

Billionaire money managers reduced their holdings in these popular stocks last quarter, but was it a smart move?

Investing | May 09, 2016

Why Alere Inc. Stock Plummeted 22.9% in April

Offhand comments from Abbott's CEO, and a confusing statement from Alere makes a pending acquisition doubtful.

Investing | May 04, 2016

Alnylam Pharmaceuticals, Inc.'s Double-Digit "Earnings" Fall

The biotech's numbers are meaningless, but an update on one of its programs sent the stock down.

Investing | April 20, 2016

What's Behind Alere Inc.'s Sinking Shares Today

Less-than-convincing comments from acquirer Abbott Labs are causing a sell-off.

Results 1 - 10 of 449 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare